参考文献/References:
[1] GBD 2016 Healthcare Access and Quality Collaborators.Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations:a systematic analysis from the global burden of disease study 2016[J].Lancet,2018,391:2236-2271.
[2]Ayanian JZ,Markel H.Donabedian’s lasting framework for health care quality[J].N Engl J Med,2016,375:205-207.
[3]中华人民共和国国家卫生健康委员会办公厅.国家卫生健康委办公厅关于印发心血管疾病介入等4个介入类诊疗技术临床应用管理规范的通知[EB/OL].https:∥www.nhc.gov.cn/yzygj/c100068/201911/a4fccc8dd088417f99c892276da6dc 93.shtml,2019-11-25.
General Office of the National Health Commission of the People’s Republic of China.Notice on issuing clinical management standards for cardiovascular interventional andother four interventional techniques[EB/OL].https:∥www.nhc.gov.cn/yzygj/c100068/201911/a4fccc8dd088417f9 9c892276da6dc93.shtml,2019-11-25.
[4]中华人民共和国国家卫生健康委员会办公厅.国家卫生健康委办公厅关于印发2025年国家医疗质量安全改进目标的通知[EB/OL].https:∥www.nhc.gov.cn/yzygj/c100068/202503/ad63fb8ce9e24013a68db52049ecc524.shtml,2025-03-21.
General Office of the National Health Commission of the People’s Republic of China.Notice on the National Targets for Medical Quality and Safety Improvement(2025)[EB/OL].https:∥www.nhc.gov.cn/yzygj/c100068/202503/ad63fb8ce 9e24013a68db52049ecc524.shtml,2025-03-21.
[5]王馨迎,宋竞赛,李 帆,等.基于德尔菲法和层次分析法构建儿童分剂量用药风险指标评价体系[J].儿科药学杂志,2025,31:16-20.
Wang XY,Song JS,Li F,et al.Construction of Risk Assessment Indicator System for Dose-Splitting Medication in Children Based on Delphi Method and Analytic Hierarchy Process[J].Joumal of Pediatric Pharmacy,2025,31:16-20.
[6]李增辉,高嗣法,马旭东,等.新重症医学医疗质量控制指标体系构建[J].中国卫生质量管理,2022,29:26-29.
Li ZH,Gao SF,Ma XD,et al.Construction of a new quality control indicator system for intensive care medicine[J].Chin J Health Qual Manag,2022,29:26-29.
[7]宇 斐,柴建军,胡冰水,等.基于德尔菲法和层次分析法的现代医院门诊医疗质控指标体系构建与应用[J].中国医院,2021,25:36-39.
Yu F,Chai JJ,Hu BS,et al.Construction and application of an outpatient medical quality control indicator system based on Delphi-AHP method[J].Chin Hosp,2021,25:36-39.
[8]龚韩湘.应用Delphi-AHP法构建紧急医学救援能力评价指标体系[J].中国卫生质量管理,2019,26:136-139.
Gong HX.Construction of an emergency medical rescue capability evaluation index system using Delphi-AHP method[J].Chin J Health Qual Manag,2019,26:136-139.
[9]战 旗,魏水易,顾文华.德尔菲法在药学工作中的应用[J].药学实践杂志,2002,20:122-124.
Zhan Q,Wei SY,Gu WH.Application of Delphi method in pharmaceutical practice[J].J Pharm Pract,2002,20:122-124.
[10]程 琮,刘一志,王如德.Kendall协调系数W检验及其SPSS实现[J].泰山医学院学报,2010,31:487-490.
Cheng C,Liu YZ,Wang RD.The Kendall’s W test and its implementation in SPSS[J].J Taishan Med Coll,2010,31:487-490.
[11]国家综合介入技术质控中心.经动脉化疗栓塞(TACE)治疗肝癌临床应用管理规范及质量控制指标(2024版)[J].中华肝脏病杂志,2024,32:1098-1104.
National Center for Comprehensive Interventional Technology Quality Control.Clinical application standards and quality control indicators for TACE in hepatocellular carcinoma(2024 edition)[J].Chin J Hepatol,2024,32:1098-1104.
[12]中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版)[J].中华肝脏病杂志,2024,32:581-630.
Department of Medical Administration,National Health Commission.Guidelines for the diagnosis and treatment of primary liver cancer(2024 edition)[J].Chin J Hepatol,2024,32:581-630.
[13]中国医师协会介入医师分会临床诊疗指南专委会.中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南(2023年版)[J].中华医学杂志,2023,103:2674-2694.
Chinese Society of Interventional Physicians.Clinical practice guidelines for TACE in hepatocellular carcinoma(2023 edition)[J].Natl Med J China,2023,103:2674-2694.
[14]霍晓川,高 峰.急性缺血性卒中血管内治疗中国指南2023[J].中国卒中杂志,2023,18:684-711.
Huo XC,Gao F.Chinese guidelines for endovascular treatment of acute ischemic stroke(2023)[J].Chin J Stroke,2023,18:684-711.
[15]王拥军,缪中荣,李子孝,等.脑梗死医疗质量控制指标(2020年版)[J].中国卒中杂志,2024,19:35-43.
Wang YJ,Miao ZR,Li ZX,et al.Quality control indicators for cerebral infarction(2020 version)[J].Chin J Stroke,2024,19:35-43.
[16]中华人民共和国国家卫生健康委员会.脑血管病防治指南(2024年版)[J].磁共振成像,2025,16:1-8.
National Health Commission of the PRC.Guidelines for prevention and treatment of cerebrovascular diseases(2024 edition)[J].Magn Reson Imaging,2025,16:1-8.
[17]中国医师协会放射性粒子治疗技术专家委员会.放射性粒子植入治疗技术管理规范(2017年版)[J].中华医学杂志,2017,97:1450-1451.
Chinese Society of Radiation Brachytherapy.Technical management standards for radioactive seed implantation(2017 edition)[J].Natl Med J China,2017,97:1450-1451.
[18]中国医师协会介入医师分会,中华医学会放射学分会介入专业委员会.下肢深静脉血栓形成介入治疗规范的专家共识(第2版)[J].中华医学杂志,2019,98:1813-1821.
Chinese Society of Interventional Physicians &Radiology Branch of CMA.Expert consensus on interventional treatment of lower extremity deep venous thrombosis(2nd edition)[J].Natl Med J China,2019,98:1813-1821.
[19]Kakkos SK,Gohel M,Baekgaard N,et al.European Society for Vascular Surgery(ESVS)2021 clinical practice guidelines on the management of venous thrombosis[J].Eur J Vasc Endovasc Surg,2021,61:9-82.
[20]Mazzolai L,Ageno W,Alatri A,et al.Second consensus document on diagnosis and management of acute deep vein thrombosis[J].Eur J Prev Cardiol,2022,29:1248-1263.
[21]上海市医学会肿瘤内科专科分会,长三角肿瘤专科联盟.上臂完全植入式静脉给药装置临床应用专家共识(2022版)[J].介入放射学杂志,2023,32:2-8.
Shanghai Society of Medical Oncology & Yangtze River Delta Oncology Alliance.Expert consensus on arm totally implanted venous access ports(2022 edition)[J].J Interv Radiol(China),2023,32:2-8.
[22]中国医师协会介入医师分会.植入式给药装置介入专家共识[J].中华医学杂志,2019,99:484-489.
Chinese Society of Interventional Physicians.Expert consensus on interventional implantation of infusion devices[J].Natl Med J China,2019,99:484-489.
(收稿日期:2025-09-28)
(本文编辑:新 宇)